Anhui Anke Biotechnology expressed on the interactive platform that the company holds 20.06% equity of Borson Genei Medical Technology (Suzhou) Co., Ltd. Through the cooperation with Borson Genei, the company has entered the field of cell therapy, which is an important part of the company's layout in cutting-edge biotechnology.
安科生物：持有博生吉20.06%股权
Anhui Anke Biotechnology: Holds 20.06% equity of Borson Genei
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated